Real Estate

Hong Kong’s Hang Seng to remove Evergrande from its China Enterprises index

Products You May Like

A housing complex by Chinese property developer Evergrande in Beijing. The indebted Evergrande has remitted the funds for a key interest payment that was due Sept. 23 — ahead of a 30-day grace period, Chinese state media Securities Times reported.
Noel Celis | AFP | Getty Images

Hong Kong’s benchmark provider Hang Seng announced it will remove troubled Chinese real estate developer Evergrande from one of its indexes — the China Enterprise index.

At the same time, it’s set to add Chinese technology giants JD and Netease to its main benchmark Hang Seng index. All the changes will take effect Dec. 6.

The index provider did not provide a reason for the decision to remove Evergrande from the 50-stock China Enterprise index.

The embattled property developer has been snowed under by debt problems, and warned in September that it could default. While the real estate giant has managed to cough up the cash to make some interest payments so far, it’s future still hangs in the balance and S&P Global Ratings said last week it could still default.

Evergrande’s stock dipped 1.44% on Monday morning. Year to date, the stock has plunged more than 80%.

In place of Evergrande, Hang Seng is adding biopharmaceuticals firm Innovent Biologics to the China Enterprise index.

As for changes on the Hang Seng index, China Resources Beer and ENN Energy Holdings will be added to the index in addition to the inclusion of JD and Netease. The latest update increases the number of stocks under the main index to 64, from the current 60 stocks.

Shares of JD jumped nearly 2% on Monday morning, while Netease was up nearly 3%.

Products You May Like

Articles You May Like

Senate debates taxes ahead of Trump’s 2025 expirations. It’s a ‘make-or-break moment,’ lawmaker says
Voss Capital wants to maximize shareholder value at International Money Express. How it may play out
Statutory vs. Effective Tax Rates: Why Do Higher Taxes Not Necessarily Lead to Increased Revenues?
When to book holiday travel this fall: ‘That window of low prices is brief,’ economist says
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Leave a Reply

Your email address will not be published. Required fields are marked *